Published in Infect Immun on February 01, 2004
Unique features of a highly pathogenic Campylobacter jejuni strain. Infect Immun (2006) 5.21
Comparative genomic analysis of Campylobacter jejuni strains reveals diversity due to genomic elements similar to those present in C. jejuni strain RM1221. J Clin Microbiol (2006) 2.27
The crucial role of Campylobacter jejuni genes in anti-ganglioside antibody induction in Guillain-Barre syndrome. J Clin Invest (2004) 2.25
Comparative phylogenomics of the food-borne pathogen Campylobacter jejuni reveals genetic markers predictive of infection source. Proc Natl Acad Sci U S A (2005) 2.04
Comparison of Campylobacter jejuni lipooligosaccharide biosynthesis loci from a variety of sources. J Clin Microbiol (2005) 1.91
Design, validation, and application of a seven-strain Staphylococcus aureus PCR product microarray for comparative genomics. Appl Environ Microbiol (2005) 1.73
The Bifidobacterium dentium Bd1 genome sequence reflects its genetic adaptation to the human oral cavity. PLoS Genet (2009) 1.64
Genome sequence of a clinical isolate of Campylobacter jejuni from Thailand. Infect Immun (2007) 1.61
Similarity and differences in the Lactobacillus acidophilus group identified by polyphasic analysis and comparative genomics. J Bacteriol (2006) 1.46
Characterization of lipooligosaccharide-biosynthetic loci of Campylobacter jejuni reveals new lipooligosaccharide classes: evidence of mosaic organizations. J Bacteriol (2008) 1.24
Comparative genomic analysis of Campylobacter jejuni associated with Guillain-Barré and Miller Fisher syndromes: neuropathogenic and enteritis-associated isolates can share high levels of genomic similarity. BMC Genomics (2007) 1.20
Genomic diversity in Campylobacter jejuni: identification of C. jejuni 81-176-specific genes. J Clin Microbiol (2005) 1.17
Genetic background of IL-10(-/-) mice alters host-pathogen interactions with Campylobacter jejuni and influences disease phenotype. Microb Pathog (2008) 1.10
MLST clustering of Campylobacter jejuni isolates from patients with gastroenteritis, reactive arthritis and Guillain-Barré syndrome. J Appl Microbiol (2009) 1.08
Porphyromonas gingivalis strain diversity. J Clin Microbiol (2009) 1.08
Large-scale genetic variation of the symbiosis-required megaplasmid pSymA revealed by comparative genomic analysis of Sinorhizobium meliloti natural strains. BMC Genomics (2005) 1.03
Fingerprinting of Campylobacter jejuni by using resolution-optimized binary gene targets derived from comparative genome hybridization studies. Appl Environ Microbiol (2006) 1.02
Comparative genomic analysis of clinical strains of Campylobacter jejuni from South Africa. PLoS One (2008) 0.99
Expanded multilocus sequence typing and comparative genomic hybridization of Campylobacter coli isolates from multiple hosts. Appl Environ Microbiol (2010) 0.96
Detection and genotyping of Arcobacter and Campylobacter isolates from retail chicken samples by use of DNA oligonucleotide arrays. Appl Environ Microbiol (2007) 0.91
Common genomic features of Campylobacter jejuni subsp. doylei strains distinguish them from C. jejuni subsp. jejuni. BMC Microbiol (2007) 0.89
Comparative studies of Campylobacter jejuni genomic diversity reveal the importance of core and dispensable genes in the biology of this enigmatic food-borne pathogen. Curr Opin Biotechnol (2009) 0.87
Genomics-based molecular epidemiology of Campylobacter jejuni isolates from feedlot cattle and from people in Alberta, Canada. J Clin Microbiol (2008) 0.85
Identification of DNA sequence variation in Campylobacter jejuni strains associated with the Guillain-Barré syndrome by high-throughput AFLP analysis. BMC Microbiol (2006) 0.81
Characteristics of lipo-oligosaccharide loci of Campylobacter jejuni isolates associated with Guillain-Barré Syndrome from Hebei, China. Int J Mol Sci (2010) 0.75
The genome sequence of the food-borne pathogen Campylobacter jejuni reveals hypervariable sequences. Nature (2000) 17.14
A whole-genome microarray reveals genetic diversity among Helicobacter pylori strains. Proc Natl Acad Sci U S A (2000) 6.85
Whole genome comparison of Campylobacter jejuni human isolates using a low-cost microarray reveals extensive genetic diversity. Genome Res (2001) 4.09
Improved analytical methods for microarray-based genome-composition analysis. Genome Biol (2002) 3.31
Involvement of a plasmid in virulence of Campylobacter jejuni 81-176. Infect Immun (2000) 3.11
Gene expression profile of Campylobacter jejuni in response to growth temperature variation. J Bacteriol (2003) 2.00
Infectious origins of, and molecular mimicry in, Guillain-Barré and Fisher syndromes. Lancet Infect Dis (2001) 1.93
Restriction fragment length polymorphism analysis and random amplified polymorphic DNA analysis of Campylobacter jejuni strains isolated from patients with Guillain-Barré syndrome. J Infect Dis (1997) 1.75
DNA sequence and mutational analyses of the pVir plasmid of Campylobacter jejuni 81-176. Infect Immun (2002) 1.68
Use of an open-reading frame-specific Campylobacter jejuni DNA microarray as a new genotyping tool for studying epidemiologically related isolates. J Infect Dis (2003) 1.67
Acute motor axonal neuropathy: an antibody-mediated attack on axolemma. Ann Neurol (1996) 1.59
A Campylobacter jejuni gene associated with immune-mediated neuropathy. Nat Med (2001) 1.52
Molecular population genetic analysis of Campylobacter jejuni HS:19 associated with Guillain-Barré syndrome and gastroenteritis. J Infect Dis (2001) 1.40
Campylobacter jejuni from patients with Guillain-Barré syndrome preferentially expresses a GD(1a)-like epitope. Infect Immun (2002) 1.40
Immune attack on the Schwann cell surface in acute inflammatory demyelinating polyneuropathy. Ann Neurol (1996) 1.34
Molecular mimicry in Campylobacter jejuni and Helicobacter pylori lipopolysaccharides: contribution of gastrointestinal infections to autoimmunity. J Autoimmun (2001) 1.10
Absence of clonality of Campylobacter jejuni in serotypes other than HS:19 associated with Guillain-Barré syndrome and gastroenteritis. J Infect Dis (2001) 1.07
Human autoimmune neuropathies. Annu Rev Neurosci (1998) 0.93
What are the consequences of the disappearing human microbiota? Nat Rev Microbiol (2009) 5.62
The prevalence of fluoroquinolone resistance mechanisms in colonizing Escherichia coli isolates recovered from hospitalized patients. Clin Infect Dis (2010) 5.34
Disruption of the epithelial apical-junctional complex by Helicobacter pylori CagA. Science (2003) 5.23
Microbiology in the post-genomic era. Nat Rev Microbiol (2008) 4.88
Improved analytical methods for microarray-based genome-composition analysis. Genome Biol (2002) 3.31
Global transposon mutagenesis and essential gene analysis of Helicobacter pylori. J Bacteriol (2004) 3.25
Persistent bacterial infections: the interface of the pathogen and the host immune system. Nat Rev Microbiol (2004) 3.23
Point: developing a curriculum in clinical pathology. Clin Chem (2006) 2.92
Salmonella typhimurium persists within macrophages in the mesenteric lymph nodes of chronically infected Nramp1+/+ mice and can be reactivated by IFNgamma neutralization. J Exp Med (2004) 2.78
Genomic comparison of Salmonella enterica serovars and Salmonella bongori by use of an S. enterica serovar typhimurium DNA microarray. J Bacteriol (2003) 2.65
Caenorhabditis elegans: plague bacteria biofilm blocks food intake. Nature (2002) 2.54
The role of prophage-like elements in the diversity of Salmonella enterica serovars. J Mol Biol (2004) 2.45
pH-regulated gene expression of the gastric pathogen Helicobacter pylori. Infect Immun (2003) 2.41
An open letter to Elias Zerhouni. Science (2005) 2.19
Cag pathogenicity island-specific responses of gastric epithelial cells to Helicobacter pylori infection. Proc Natl Acad Sci U S A (2002) 2.16
The genome-sequenced variant of Campylobacter jejuni NCTC 11168 and the original clonal clinical isolate differ markedly in colonization, gene expression, and virulence-associated phenotypes. J Bacteriol (2004) 2.14
Destroying the life and career of a valued physician-scientist who tried to protect us from plague: was it really necessary? Clin Infect Dis (2005) 2.06
Gene expression profiling of Helicobacter pylori reveals a growth-phase-dependent switch in virulence gene expression. Infect Immun (2003) 2.02
Evolutionary genetics: CCR5 mutation and plague protection. Nature (2004) 1.97
Phenotypic and genotypic characterization of fecal Escherichia coli isolates with decreased susceptibility to fluoroquinolones: results from a large hospital-based surveillance initiative. J Infect Dis (2006) 1.96
Helicobacter pylori enter and survive within multivesicular vacuoles of epithelial cells. Cell Microbiol (2002) 1.93
Test characteristics of perirectal and rectal swab compared to stool sample for detection of fluoroquinolone-resistant Escherichia coli in the gastrointestinal tract. Antimicrob Agents Chemother (2005) 1.93
Risk factors for fluconazole-resistant Candida glabrata bloodstream infections. Arch Intern Med (2009) 1.86
Surveillance cultures for detection of methicillin-resistant Staphylococcus aureus: diagnostic yield of anatomic sites and comparison of provider- and patient-collected samples. Infect Control Hosp Epidemiol (2009) 1.85
Microarray detection of human parainfluenzavirus 4 infection associated with respiratory failure in an immunocompetent adult. Clin Infect Dis (2006) 1.84
Longitudinal trends in fluoroquinolone resistance among Enterobacteriaceae isolates from inpatients and outpatients, 1989-2000: differences in the emergence and epidemiology of resistance across organisms. Clin Infect Dis (2004) 1.83
Impact of inadequate initial antimicrobial therapy on mortality in infections due to extended-spectrum beta-lactamase-producing enterobacteriaceae: variability by site of infection. Arch Intern Med (2005) 1.82
virK, somA and rcsC are important for systemic Salmonella enterica serovar Typhimurium infection and cationic peptide resistance. Mol Microbiol (2003) 1.80
Imipenem resistance among pseudomonas aeruginosa isolates: risk factors for infection and impact of resistance on clinical and economic outcomes. Infect Control Hosp Epidemiol (2006) 1.76
Medicine. The intangible value of vaccination. Science (2002) 1.75
Microarray-based detection of Salmonella enterica serovar Typhimurium transposon mutants that cannot survive in macrophages and mice. Infect Immun (2005) 1.74
Helicobacter pylori usurps cell polarity to turn the cell surface into a replicative niche. PLoS Pathog (2009) 1.73
The Campylobacter jejuni stringent response controls specific stress survival and virulence-associated phenotypes. Mol Microbiol (2005) 1.72
Sequence-based identification of aerobic actinomycetes. J Clin Microbiol (2004) 1.70
Redefining bacterial populations: a post-genomic reformation. Nat Rev Genet (2002) 1.70
Complex pattern of Mycobacterium marinum gene expression during long-term granulomatous infection. Proc Natl Acad Sci U S A (2002) 1.70
Frontal and stealth attack strategies in microbial pathogenesis. Nature (2004) 1.69
Gastric MALT lymphoma B cells express polyreactive, somatically mutated immunoglobulins. Blood (2009) 1.68
Use of an open-reading frame-specific Campylobacter jejuni DNA microarray as a new genotyping tool for studying epidemiologically related isolates. J Infect Dis (2003) 1.67
Reemergence of gram-negative health care-associated bloodstream infections. Arch Intern Med (2006) 1.63
Growth phase-dependent response of Helicobacter pylori to iron starvation. Infect Immun (2003) 1.60
Asaia bogorensis peritonitis identified by 16S ribosomal RNA sequence analysis in a patient receiving peritoneal dialysis. Am J Kidney Dis (2004) 1.58
Prolonged incubation and extensive subculturing do not increase recovery of clinically significant microorganisms from standard automated blood cultures. Clin Infect Dis (2005) 1.57
Significance analysis of lexical bias in microarray data. BMC Bioinformatics (2003) 1.55
Fluoroquinolone-resistant Pseudomonas aeruginosa: assessment of risk factors and clinical impact. Am J Med (2006) 1.47
Identification of optimal combinations for empirical dual antimicrobial therapy of Pseudomonas aeruginosa infection: potential role of a Combination Antibiogram. Infect Control Hosp Epidemiol (2006) 1.45
Evaluation of mannitol salt agar, CHROMagar Staph aureus and CHROMagar MRSA for detection of meticillin-resistant Staphylococcus aureus from nasal swab specimens. J Med Microbiol (2007) 1.44
The Salmonella-containing vacuole is a major site of intracellular cholesterol accumulation and recruits the GPI-anchored protein CD55. Cell Microbiol (2002) 1.42
Comparison of unit-specific and hospital-wide antibiograms: potential implications for selection of empirical antimicrobial therapy. Infect Control Hosp Epidemiol (2006) 1.42
Campylobacter jejuni cst-II polymorphisms and association with development of Guillain-Barré syndrome. Neurology (2007) 1.40
Risk factors for increasing multidrug resistance among extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella species. Clin Infect Dis (2005) 1.39
Growth inhibition of Trichophyton species by Pseudomonas aeruginosa. Arch Dermatol (2007) 1.39
Risk factors for and outcomes of bloodstream infection caused by extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella species in children. Pediatrics (2005) 1.33
Phosphorylation-independent effects of CagA during interaction between Helicobacter pylori and T84 polarized monolayers. J Infect Dis (2004) 1.32
Prevalence of CTX-M beta-lactamases in Philadelphia, Pennsylvania. J Clin Microbiol (2009) 1.27
LuxS is required for persistent pneumococcal carriage and expression of virulence and biosynthesis genes. Infect Immun (2004) 1.26
Transcriptional response in the peripheral blood of patients infected with Salmonella enterica serovar Typhi. Proc Natl Acad Sci U S A (2009) 1.22
Chronic Helicobacter pylori infection with Sydney strain 1 and a newly identified mouse-adapted strain (Sydney strain 2000) in C57BL/6 and BALB/c mice. Infect Immun (2004) 1.21
Modulation of virulence by two acidified nitrite-responsive loci of Salmonella enterica serovar Typhimurium. Infect Immun (2003) 1.20
Use of BBL CHROMagar MRSA medium for identification of methicillin-resistant Staphylococcus aureus directly from blood cultures. J Clin Microbiol (2006) 1.19
The Campylobacter jejuni dccRS two-component system is required for optimal in vivo colonization but is dispensable for in vitro growth. Mol Microbiol (2004) 1.17
Self-collected versus provider-collected vaginal swabs for the diagnosis of bacterial vaginosis: an assessment of validity and reliability. J Clin Epidemiol (2003) 1.17
mig-14 is a Salmonella gene that plays a role in bacterial resistance to antimicrobial peptides. J Bacteriol (2002) 1.16
Distinct gene expression profiles characterize the histopathological stages of disease in Helicobacter-induced mucosa-associated lymphoid tissue lymphoma. Proc Natl Acad Sci U S A (2003) 1.16
Culturing stool specimens for Campylobacter spp., Pennsylvania, USA. Emerg Infect Dis (2012) 1.16
Breaking into the epithelial apical-junctional complex--news from pathogen hackers. Curr Opin Cell Biol (2004) 1.15
The adaptor molecules LAT and SLP-76 are specifically targeted by Yersinia to inhibit T cell activation. J Exp Med (2005) 1.15
Mig-14 is an inner membrane-associated protein that promotes Salmonella typhimurium resistance to CRAMP, survival within activated macrophages and persistent infection. Mol Microbiol (2005) 1.14
Limiting the emergence of extended-spectrum Beta-lactamase-producing enterobacteriaceae: influence of patient population characteristics on the response to antimicrobial formulary interventions. Infect Control Hosp Epidemiol (2006) 1.11
Protective immunity against Helicobacter is characterized by a unique transcriptional signature. Proc Natl Acad Sci U S A (2003) 1.10
Molecular mimicry in Campylobacter jejuni: role of the lipo-oligosaccharide core oligosaccharide in inducing anti-ganglioside antibodies. FEMS Immunol Med Microbiol (2007) 1.10
Analysis and presentation of cumulative antimicrobial susceptibility data (antibiograms): substantial variability across medical centers in the United States. Infect Control Hosp Epidemiol (2006) 1.08
Delineation of upstream signaling events in the salmonella pathogenicity island 2 transcriptional activation pathway. J Bacteriol (2004) 1.08
Comparative whole genome sequence analysis of the carcinogenic bacterial model pathogen Helicobacter felis. Genome Biol Evol (2011) 1.05
Profiling of microdissected gastric epithelial cells reveals a cell type-specific response to Helicobacter pylori infection. Gastroenterology (2004) 1.03
The role of antigenic drive and tumor-infiltrating accessory cells in the pathogenesis of helicobacter-induced mucosa-associated lymphoid tissue lymphoma. Am J Pathol (2005) 1.00
Changes in the prevalence of vancomycin-resistant enterococci in response to antimicrobial formulary interventions: impact of progressive restrictions on use of vancomycin and third-generation cephalosporins. Clin Infect Dis (2003) 0.99
Central nervous system infections due to Abiotrophia and Granulicatella species: an emerging challenge? Diagn Microbiol Infect Dis (2004) 0.98
Streptococcus pneumoniae nasopharyngeal colonization induces type I interferons and interferon-induced gene expression. BMC Genomics (2009) 0.98
Fungal rhinosinusitis: a retrospective microbiologic and pathologic review of 400 patients at a single university medical center. Int J Otolaryngol (2012) 0.96
Gastrointestinal tract colonization with fluoroquinolone-resistant Escherichia coli in hospitalized patients: changes over time in risk factors for resistance. Infect Control Hosp Epidemiol (2009) 0.95
Risk factors for and impact of infection or colonization with aztreonam-resistant Pseudomonas aeruginosa. Infect Control Hosp Epidemiol (2007) 0.92
Early pregnancy changes in bacterial vaginosis-associated bacteria and preterm delivery. Paediatr Perinat Epidemiol (2014) 0.88
Risk factors for gastrointestinal tract colonization with extended-spectrum β-lactamase (ESBL)-producing Escherichia coli and Klebsiella species in hospitalized patients. Infect Control Hosp Epidemiol (2012) 0.88
Chloramphenicol resistance in vancomycin-resistant enterococcal bacteremia: impact of prior fluoroquinolone use? Infect Control Hosp Epidemiol (2004) 0.88
First trimester bacterial vaginosis, individual microorganism levels, and risk of second trimester pregnancy loss among urban women. Fertil Steril (2007) 0.87
Disseminated Mycoplasma orale infection in a patient with common variable immunodeficiency syndrome. Diagn Microbiol Infect Dis (2002) 0.85
Helicobacter pylori and gastric cancer: what can be learned by studying the response of gastric epithelial cells to the infection? Cancer Epidemiol Biomarkers Prev (2005) 0.84
Risk factors for efflux pump overexpression in fluoroquinolone-resistant Escherichia coli. J Infect Dis (2012) 0.84
Yield of methicillin-resistant Staphylococcus aureus on moist swabs versus dry swabs. Am J Infect Control (2013) 0.84
In situ hybridization for Coccidioides immitis 5.8S ribosomal RNA sequences in formalin-fixed, paraffin-embedded pulmonary specimens using a locked nucleic acid probe: a rapid means for identification in tissue sections. Diagn Mol Pathol (2010) 0.84